Nmnat1 as a Neuroprotective Agent in Murine Glaucoma

Principal Investigator
Milam A. Brantley, Jr., MD, PhD
Vanderbilt University Medical Center
Nashville, TN, USA
About the Research Project
Program
Award Type
Standard
Award Amount
$90,000
Active Dates
April 01, 2006 - March 31, 2009
Grant ID
G2006020
Goals
The purpose of this study is to evaluate the ability of overexpression of Nmnat1 to slow axonal degeneration in two mouse models of optic neuropathy.
Grantee institution at the time of this grant: Washington University
Summary
Glaucoma is the second leading cause of blindness worldwide and is characterized by degeneration of retinal ganglion cells (RGCs), whose axons make up the optic nerve. It is generally accepted that degeneration of the RGC axons precedes programmed death of the cell bodies themselves. Recent tissue culture experiments have shown that increased expression of the Nmnat1 gene can slow the rate of axonal degeneration in the face of axonal injury. The purpose of this study is to evaluate the ability of overexpression of Nmnat1 to slow axonal degeneration in two mouse models of optic neuropathy. In the first model, a short period of very high eye pressure will be used to cause RGC damage over 1-2 weeks. The second model uses application of laser to the eye to moderately and stably raise eye pressure, closely simulating glaucoma. A virus vector containing the Nmnat1 gene will be injected into eyes from each of these models, and the RGCs will be evaluated both morphologically and functionally to determine if Nmnat1 can protect the RGCs against damage. This study will efficiently assess the potential of Nmnat1 to serve as an effective anti-glaucoma agent.
Grants
Related Grants
National Glaucoma Research
Understanding How Variants in LOXL1 Affect Pseudoexfoliation Glaucoma Risk
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Hannah Youngblood, PhD
Understanding How Variants in LOXL1 Affect Pseudoexfoliation Glaucoma Risk
Active Dates
July 01, 2024 - June 30, 2026

Principal Investigator
Hannah Youngblood, PhD
National Glaucoma Research
Retinal Ganglion Cell Axon Degeneration in a 3D Microfluidic Hydrogel Model
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Shruti Patil, PhD
Retinal Ganglion Cell Axon Degeneration in a 3D Microfluidic Hydrogel Model
Active Dates
July 01, 2024 - June 30, 2026

Principal Investigator
Shruti Patil, PhD
National Glaucoma Research
The Role of Microtubules in Glaucomatous Schlemm’s Canal Mechanobiology
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Haiyan Li, PhD
The Role of Microtubules in Glaucomatous Schlemm’s Canal Mechanobiology
Active Dates
July 01, 2024 - June 30, 2026

Principal Investigator
Haiyan Li, PhD